BioPartner UK

We are proud to share that Scendea is now a certified B Corporation™! Watch our journey below and learn more about what being a B Corp means to Scendea. - #BCorp #BCorpCertified #BusinessAsAForceForGood #ESG #Sustainability #LifeAtScendea

🌍 If you’re a UK business selling or wanting to sell goods or services outside the UK, BioPartner UK has a dedicated export support page to help increase your international opportunities biopartner.co.uk/export-support #BioPartner #ExportSupport #InternationalTrade #ATO

EXHIBITORS: Boost your profile at the #Bionow #Neuroscience conference on 9 July, with #exhibitor packages starting at just £450, including 2 delegate passes. Get your company in front of academics, clinicians and industry leaders. Find out more: bionow.glueup.com/resources/prot…

The EMA has updated a series of assessment timetable documents relating to initial marketing authorisation applications. Get in touch to discuss how the updated EMA timetables may affect your strategy: scendea.com/contact

Our Chief Executive Officer Jeremy Skillington & Chief Financial Officer Ian O'Connell will be attending @IAmBiotech Bio International Convention, one of the world’s leading events for the biotechnology and life sciences industry. 📍San Diego, US 🗓️22-25 June 2026 With interim data from the POLB 001 TOPICAL trial expected this summer, alongside the recent Canadian patent grant, momentum continues to build across the programme. The team looks forward to engaging with potential partners at BIO to discuss the clinical progress, our expanding IP portfolio, and broader commercial opportunity ahead. If you’re attending BIO 2026, connect with our team via the BIOpartnering platform. Learn more: convention.bio.org #POLB #BIO2026 #Biotech #LifeSciences #HealthcareInnovation #Biotechnology #Networking #Innovation #BIOInternational

🙏 A big thank you to the #ECB2026 sponsors & exhibitors! Your support helps young scientists attend the congress through reduced registration fees 🧬🌍 Interested in becoming a sponsor or exhibitor? 🔗 ecb2026.com/sponsors-and-e… #Biotechnology #LifeSciences

Make the most of #BIO26's advanced rates with an additional $405 off when you register through @BioPartner Register and save today! biopartner.co.uk/bio T&Cs apply.

LAST CHANCE TO BOOK: 💪 Empowering #WomenInBiotech 💪 is at BioCity Glasgow THIS THU so join #Bionow for this inclusive and FREE (for Members) #networking event sharing women's success stories from #academia, #biotech and #LifeSciences. ALL welcome! bionow.glueup.com/event/empoweri…

To enhance our expertise in the Cytokine Release Syndrome space we have appointed Dr Adrian Kilcoyne to our Scientific Advisory Board. Dr Kilcoyne bring over 20 years of clinical expertise with strategic drug development leadership, focusing on innovative therapies that address unmet medical needs in oncology and immunology and, in particular, brings deep knowledge of haematological malignancies, T-cell therapies and Cytokine Release Syndrome. Adrian’s wealth of experience will provide further support to our established team of experts as we progress POLB 001 through the TOPICAL trial with the ultimate aim of transforming cancer care for patients and healthcare systems. Learn more about Dr Kilcoyne’s experience and read the full announcement here: londonstockexchange.com/news-article/P… #POLB #SAB #ScientificAdvisory #BoardMember #AIM #Cancer #Oncology #ScientificExpert

And that was the 2025 #BionowAwards! Thank you to all our nominees, attendees and sponsors for making the evening truly special. Now head over to our event summary to check out the full list of award winners! bionow.co.uk/news/honouring… #LifeSciences #Networking #CelebratingSuccess

Develop your leadership and management skills with our 17 free online modules. They share the latest leadership tools to enable you to reflect on and practise new approaches. Login or register on NIHR Learn to find out more: learn.nihr.ac.uk/course/view.ph…

The @US_FDA has published a paper on a plausible mechanism pathway, a #regulatory framework to accelerate approval of bespoke, #patient-specific #therapies when traditional trials are not feasible. - For more information on this guidance, get in touch: scendea.com/contact

The @BioPartner News Roundup is out, featuring the #latestnews from our members, @Stablepharma1 and @_REPROCELL. We want to shout out our event partner @MedTechWorld. Catch the latest on our website – https:// lnkd.in/e6KUE5Zz #Lifesciences #NewsUpdate

The @US_FDA has published a guidance titled, “Scientific Considerations in Demonstrating #Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies (CES)”. - #guidanceupdate #scientificconsiderations #USregulatorysupport

Video clips & a post-event update from CEO Jeremy Skillington at this weeks' EBD Group's BIO-Europe in Vienna! The team were delighted to join so many industry colleagues to explore the future of biotech and pharma. A big thank you to everyone who took the time to connect with our team. We look forward to continuing the momentum and driving meaningful outcomes in the life sciences. #POLB #BIOEUROPE #Vienna #Conference #Pharma #Biotech

What an incredible week at #BIOEurope! A huge thank you to everyone who stopped by the #UKPavilion, your energy and our conversations made it a truly productive outing. BioPartner UK is proud to have showcased the best of #UKLifesciences with our amazing #UKDelegation. 🇬🇧

The #BionowAwards are NOW OPEN for applications until 16 JAN! 🏆 Whether you want to nominate a stellar colleague, celebrate an investment win or showcase that amazing project, ALL are welcome to make a submission. More info: bionow.glueup.com/event/2025-bio… #CelebratingSuccess

This week is RSV Awareness Week and at hVIVO, we’re proud to be at the forefront of innovation in RSV research and development. Respiratory Syncytial Virus (RSV) continues to pose a significant global health challenge, particularly for infants, older adults, and immunocompromised individuals. At hVIVO, we provide comprehensive, end-to-end support for the development and evaluation of RSV vaccines and antiviral therapeutics through our world-leading controlled human infection models and specialist laboratory services. Let’s work together to advance RSV science and protect vulnerable populations. Learn more about our dedicated RSV human challenge trial services by clicking on the link below or reach out directly on bd@hvivo.com: hvivo.com/human-challeng… #HVO #RSVWeek #RSV #ClinicalTrials #Vaccines #Antivirals #hLAB

Our CEO provides an overview on the clear plan to deliver shareholder returns through Poolbeg’s strategic & financial highlights. 🔹Our partnering focused model of cost-effective trials have been designed to produce high-quality human data and accelerate partnering discussions on our pipeline. 🔹We have a proven team with expertise in trial execution and deal-making. 🔹Well capitalised with a cash runway into 2027 supporting the delivery of multiple key clinical milestones. We have multiple potential value catalysts ahead, check out POLB 001’s here: poolbegpharma.com/pipeline/polb-… #POLB #Strategy #Partnering #AIM #London #CashBalance

☕🍪 Get ready for Biscuits & Brew! 🍪☕ Join @BioPartner UK for an informal networking break over a hot brew and some biscuits! Let's chat all things #BIOEurope2025, #Vienna, #UKDelegation, and more. Free to Attend, Register Here: lnkd.in/emZs7JRN #Biotech #Pharma